Breye Therapeutics
PrivateLast Round
Series A
Feb 9, 2026
Total Funding Raised
$4.1M
Company Overview
Breye Therapeutics is a biopharmaceutical company developing orally administered small-molecule therapies for the treatment of retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breye Therapeutics Comparables
Compare Breye Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vantage Biosciences | 88% | |
| Opus Genetics | 80% | |
| Galimedix Therapeutics | 79% | |
Breye Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 9, 2026 | ||||
| Seed | Nov 10, 2022 |
Key People
Founding team and executive leadership
Breye Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Seed |
| Novo Holdings | Seed |
| The Export and Investment Fund of Denmark | Seed |
| BioInnovation Institute | Seed |
| Sound Bioventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2022
$4M round led by Novo Holdings and Sound Bioventures.
Breye Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Breye Therapeutics's valuation, stock price, and market status.